Mesoblast Limited
MESO · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $7,021 | $7,021 | $1,578 | $1,578 |
| % Growth | 0% | 344.9% | 0% | – |
| Cost of Goods Sold | $23,248 | $23,248 | $3,280 | $3,280 |
| Gross Profit | -$16,227 | -$16,227 | -$1,702 | -$1,702 |
| % Margin | -231.1% | -231.1% | -107.8% | -107.8% |
| R&D Expenses | $7,079 | $7,079 | $10,325 | $10,325 |
| G&A Expenses | $8,594 | $8,594 | $8,594 | $8,594 |
| SG&A Expenses | $11,061 | $11,061 | $8,594 | $8,594 |
| Sales & Mktg Exp. | $2,467 | $2,467 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $18,140 | $18,140 | $18,919 | $18,919 |
| Operating Income | -$34,367 | -$34,367 | -$20,620 | -$20,620 |
| % Margin | -489.5% | -489.5% | -1,306.7% | -1,306.7% |
| Other Income/Exp. Net | $7,322 | $7,322 | -$3,241 | -$3,241 |
| Pre-Tax Income | -$27,045 | -$27,045 | -$23,861 | -$23,861 |
| Tax Expense | $59 | $59 | $106 | $106 |
| Net Income | -$27,104 | -$27,104 | -$23,967 | -$23,967 |
| % Margin | -386% | -386% | -1,518.8% | -1,518.8% |
| EPS | -0.21 | -0.21 | -0.21 | -0.21 |
| % Growth | 0% | 0% | 0% | – |
| EPS Diluted | -0.21 | -0.21 | -0.21 | -0.21 |
| Weighted Avg Shares Out | 127,333 | 127,333 | 114,129 | 114,129 |
| Weighted Avg Shares Out Dil | 127,328 | 127,328 | 114,230 | 114,230 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $5,345 | $5,345 |
| Depreciation & Amortization | $1,593 | $1,593 | $538 | $538 |
| EBITDA | -$19,637 | -$19,637 | -$9,455 | -$9,455 |
| % Margin | -279.7% | -279.7% | -599.1% | -599.1% |